Is Citius Oncology, Inc. CTOR stock halal to invest in?

No, as of February 2026, Citius Oncology, Inc. stock (CTOR) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Citius Oncology, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Citius Oncology, Inc. and alternative halal stock options within the Tabadulat app.

How often is Citius Oncology, Inc. CTOR reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Citius Oncology, Inc. CTOR monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Citius Oncology, Inc. CTOR pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Citius Oncology, Inc. stock (CTOR) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Citius Oncology, Inc. CTOR pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Citius Oncology, Inc. stock (CTOR) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Citius Oncology, Inc. stock (CTOR) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Citius Oncology, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

CTOR

About

Citius Oncology, Inc.

CTOR

Citius Oncology Inc. operates as a clinical-stage biopharmaceutical company specializing in the development of novel therapeutics for cancer treatment. The primary function of Citius Oncology is to research and develop innovative therapies that aim to enhance the efficacy and safety profiles of current cancer treatments. The company focuses on leveraging new technology platforms and scientific advancements to address unmet medical needs in various types of cancer, impacting both the oncology and pharmaceutical sectors.Citius Oncology's significance in the market revolves around its commitment to advancing cancer therapeutics, which is a critical area due to the disease's widespread impact globally. As a clinical-stage entity, the company plays a crucial role in the pipeline of medical innovation, contributing to potential future options for cancer care. Citius Oncology partners with research institutions and other biopharmaceutical enterprises to push the boundaries of standard oncology treatments. This makes it an influential player in the biotechnology and healthcare sectors, aligning with a broader industry goal to improve patient outcomes in oncology.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Employees:

Website:

https://www.tenxkeane.com

CTOR

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Citius Oncology, Inc.

About

Citius Oncology, Inc.

CTOR

Frequently asked questions

Is Citius Oncology, Inc. CTOR stock halal to invest in?

How often is Citius Oncology, Inc. CTOR reviewed for Shariah compliance?

Does Citius Oncology, Inc. CTOR pass the AAOIFI Non Permissible Income criteria?

Does Citius Oncology, Inc. CTOR pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Citius Oncology, Inc. CTOR stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.